Forecasting Hepatitis C liver disease burden on real‐life data. Does the <i>hidden iceberg</i> matter to reach the elimination goals?Loreta A. Kondili, Giovanni Raimondo, Gloria Taliani et al.|Liver International|2018Cited by 45
Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohortLoreta A. Kondili, Federica Romano, Francesca Romana Rolli et al.|Hepatology|2017Cited by 29
Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort StudyLoreta A. Kondili, Claudio Maria Mastroianni, Maria Giovanna Quaranta et al.|Journal of Hepatology|2016Cited by 4
HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort studyLiliana Elena Weimer, O. Patti, M. Vinci et al.|Digestive and Liver Disease|2016Cited by 1